Eupraxia Pharmaceuticals (EPRX) Prepaid Assets (2022 - 2026)
Eupraxia Pharmaceuticals' (EPRX) quarterly Prepaid Assets came in at $2.6 million in Q1 2026, up 182.83% year-on-year from $913283.0 in Q1 2025, and down 33.1% on a QoQ basis from $3.9 million in Q4 2025.
Eupraxia Pharmaceuticals (EPRX) Prepaid Assets (2022 - 2026) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has 5 years of Prepaid Assets data on file, last reported at $2.6 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 182.83% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 182.83% increase from a year earlier, with the FY2025 full-year figure at $3.9 million, up 248.92% from the prior year.
- Prepaid Assets for Q1 2026 stood at $2.6 million, down from $3.9 million in the prior quarter.
- Over the last five years, Prepaid Assets for EPRX reached as high as $3.9 million in Q4 2025 and fell as low as $140928.0 in Q1 2024.
- Historically, Prepaid Assets has averaged $1.6 million across 5 years, with a median of $1.1 million in 2024.
- Across the five-year window, Prepaid Assets climbed 14.75% in 2023 and jumped 548.05% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $235903.0 in 2022, then advanced by 14.75% to $270710.0 in 2023, then soared by 308.74% to $1.1 million in 2024, then jumped by 248.92% to $3.9 million in 2025, then sank by 33.1% to $2.6 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $2.6 million in Q1 2026, $3.9 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 329.50 Mn | 329.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.58 Mn |
| Dec 31, 2025 | 3.86 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 913,283.00 |
| Dec 31, 2024 | 1.11 Mn |
| Mar 31, 2024 | 140,928.00 |
| Dec 31, 2023 | 270,710.00 |
| Dec 31, 2022 | 235,903.00 |